Jorg Simpelkamp

Title: Jorg Simpelkamp: Innovator in Lipase Immobilization

Introduction

Jorg Simpelkamp is a notable inventor based in Mulheim an der Ruhr, Germany. He has made significant contributions to the field of biochemistry, particularly in the immobilization of lipases. With a total of 2 patents, his work has implications for medical treatments related to digestive insufficiency.

Latest Patents

Simpelkamp's latest patents focus on innovative methods for immobilizing lipases. One of his patents describes the immobilization of lipases by entrapment in silica matrices. This process involves the hydrolysis of alkoxy-silicon compounds in the presence of a catalyst and various additives, including proteins and polyhydroxy compounds. The entrapped lipase can be utilized for treating digestive insufficiency in patients suffering from pancreatic diseases or cystic fibrosis. Another patent details a process for preparing immobilized lipases through reactions on a silica matrix that contains non-hydrolyzable organic substituents attached via Si--C bonds.

Career Highlights

Jorg Simpelkamp is associated with Studiengesellschaft Kohle GmbH, where he continues to advance his research in lipase immobilization. His work has garnered attention for its potential applications in healthcare and biochemistry.

Collaborations

Simpelkamp has collaborated with notable colleagues, including Manfred T Reetz and Albin Zonta, contributing to the advancement of their shared research interests.

Conclusion

Jorg Simpelkamp's innovative work in the field of lipase immobilization showcases his commitment to improving medical treatments for digestive disorders. His patents reflect a significant step forward in biochemistry and its applications in healthcare.